CME CME GroupcompanySEC Filings & Insider Trading Activity 2026
Latest CME Group (CME) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on October 24, 2025, an 8-K current report filed on April 27, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for CME Group (CME) (SEC CIK 1156375), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Global derivatives exchange operator: trading, clearing, and data services across interest rates, equities, FX, commodities, and crypto
- • Two new 2025 platform launches: BrokerTec Chicago (second CLOB for cash U.S. Treasuries co-located with futures) and FX Spot+ (connects OTC spot FX with futures liquidity)
Risk Factors
- • FMX Futures Exchange and prediction market platforms (via FanDuel JV) directly targeting CME's derivatives and event-contract segments; litigation ongoing across multiple jurisdictions
- • Basel III Endgame and potential GSIB capital surcharge changes could raise bank clearing firm capital requirements, reducing their trading activity in CME markets
Management Discussion & Analysis
- • Revenue $6,520.6M in 2025, up ~6.4% YoY from $6,130.1M; clearing & transaction fees $5,281.1M (+5.9%), market data $803.1M (+13.1%)
- • Operating margin 64.9% vs 64.1% in 2024; net income $4,072.2M vs $3,525.8M; diluted EPS $11.16 vs $9.67
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Management Discussion & Analysis
- • Revenue $1,537.6M Q3 2025, down 3% YoY from $1,584.4M Q3 2024
- • Operating margin 63.3% Q3 2025 vs 64.6% YoY, net income $908.0M vs $912.8M, EPS $2.49 stable YoY
Risk Factors
- • No material changes in risk factors from 2024 10-K disclosed in this 10-Q
- • Market volatility risk remains significant due to changing economic conditions affecting trading volumes
Annual Reports Archive10-K
AI-powered analysis of CME Group (CME) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of CME Group (CME) 10-Q quarterly reports filed with SEC EDGAR.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $5.0B | $5.6B | $6.1B | $6.5B |
| Operating Income | $3.0B | $3.4B | $3.9B | $4.2B |
| Net Income | $2.7B | $3.2B | $3.5B | $4.1B |
| Op. Margin | 60.1% | 61.6% | 64.1% | 64.9% |
| Net Margin | 53.6% | 57.8% | 57.5% | 62.5% |
| Balance Sheet | ||||
| Total Assets | $174.2B | $129.7B | $137.4B | $198.4B |
| Equity | $26.9B | $26.7B | $26.5B | $28.7B |
| ROE | 10.0% | 12.1% | 13.3% | 14.2% |
Source: XBRL financial data from CME Group (CME) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 27, 2026 | — | — | — |
8-K | Apr 22, 2026 | — | — | — |
10-K | Feb 26, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 4, 2026 | — | — | |
8-K | Feb 2, 2026 | — | — | |
10-Q | Oct 24, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Jul 25, 2025 | Jun 30, 2025 | — | |
10-Q | Apr 30, 2025 | Mar 31, 2025 | — | |
10-K | Feb 27, 2025 | Dec 31, 2024 | Analysis | |
10-Q | Nov 8, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 5, 2024 | Jun 30, 2024 | — | |
10-Q | May 1, 2024 | Mar 31, 2024 | — | |
10-K | Feb 28, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 1, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 2, 2023 | Jun 30, 2023 | — | |
10-Q | May 3, 2023 | Mar 31, 2023 | — | |
10-K | Feb 27, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 2, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 3, 2022 | Jun 30, 2022 | — | |
10-Q | May 4, 2022 | Mar 31, 2022 | — | |
10-K | Feb 25, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 3, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 5, 2021 | Jun 30, 2021 | — | |
10-Q | May 5, 2021 | Mar 31, 2021 | — | |
10-K | Feb 26, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest CME SEC filings in 2026?
CME Group (CME) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on October 24, 2025, an 8-K current report on April 27, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CME file its most recent 10-K annual report?
CME Group (CME) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CME 10-Q quarterly reports?
CME Group (CME)'s most recent 10-Q quarterly report was filed on October 24, 2025. SignalX displays every CME 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CME filed recently?
CME Group (CME)'s most recent 8-K was filed on April 27, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CME insider trading activity (Form 4)?
SignalX aggregates every CME Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CME file with the SEC?
CME Group (CME) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CME filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for CME Group (CME).
What is CME's SEC CIK number?
CME Group (CME)'s SEC CIK (Central Index Key) number is 1156375. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1156375 to look up all CME filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find CME return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from CME Group (CME) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of CME Group SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 37+ filings.